Incidence of renal insufficiency in cancer patients

Advances in Therapy

Volumn 22, Issue 4, 2005, Pages 357-362

  Dogan, Ekrem ^a   Izmirli, Mustafa ^a   Ceylan, Kadir ^a   Erkoc, Reha ^a   Sayarlioglu, Hayriye ^a   Begenik, Huseyin ^a   Alici, Suleyman ^a  

^a YUZUNCU YIL UNIVERSITY   (Turkey)

Author keywords

Cancer; Cockroft Gault; GFR

Indexed keywords

ADULT; AGED; ARTICLE; BODY SURFACE; CANCER PATIENT; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; EARLY DIAGNOSIS; FEMALE; GLOMERULUS FILTRATION RATE; HIGH RISK PATIENT; HIGH RISK POPULATION; HUMAN; INCIDENCE; KIDNEY FAILURE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE;

ADULT; AGED; AGED, 80 AND OVER; CREATININE; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; NEOPLASMS;

EID: 29344437515     PISSN: 0741238X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02850082     Document Type: Article

References (16)

1. Burstein DM, Korbet SM, Schwartz MM. Membranous glomerulonephritis and malignancy. Am J Kidney Dis. 1993;22:5-10.
2. Alpers CE, Cotran RS. Neoplasia and glomerular injury. Kidney Int. 1986;30:465-473.
3. Poch E, Almirall J, Torras A, et al. Rapidly progressive glomerulonephritis and systemic vasculitis in non-Hodgkin lymphoma. Nephrol Dial Transplant. 1991;6:51-54.
4. Marx GM, Blake GM, Galani E, et al. Evaluation of the Cockroft-Gault, Jelliffe and Wright formulae in estimating renal function in elderly cancer patients mass. Ann Oncol. 2004;15:291-295.
5. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976; 16:31-41.
6. Launay-Vacher V, Izzedine H, Rey JB, et al. Incidence of renal insufficiency in cancer patients and evaluation of information available on the use of anticancer drugs in renally impaired patients. Med Sci Monit. 2004;10:CR209-CR212.
7. Beck L. Aging changes in renal function. In: Hazzard W, Blass J, Ettinger W, Halter J, Ouslander J, eds. Principles of Geriatric Medicine and Gerontology. 4th ed. New York, NY: McGraw-Hill;1999: 767-776.
8. Bjerrum L, Andersen M, Petersen G, Kragstrup J. Exposure to potential drug interactions in primary health care. Scand J Prim Health Care. 2003;21:153-158.
9. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification and stratification. Kidney Disease Outcome Quality Initiative. Am J Kidney Dis. 2002;39(2 suppl 1): S1-S266.
10. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth DA. More accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999;130:461-470.
11. Monfardini S. Evaluation of renal function in elderly cancer patients. Ann Oncol. 2004;15: 183-184.
12. Clase C, Garg A, Kiberd B. Prevalence of low glomerular filtration in nondiabetic Americans: Third National Health and Nutrition Examination Survey (NHANES III). J Am Soc Nephrol. 2002;13:1338-1349.
13. Verhave JC, Balje-Volkers CP, Hillege HL, de Zeeuw D, de Jong PE. The reliability of different formulae to predict creatinine clearance. J Intern Med. 2003;253:563-573.
14. Poole SG, Dooley MJ, Rischin D.A. Comparison of bedside renal function estimates and measured glomerular filtration rate (Tc99mDTPA clearance) in cancer patients. Ann Oncol. 2002;13:949-955.
15. Ko C, Chaudhry S. The need for a multidisciplinary approach to cancer care. J Surg Res. 2002; 105:53-57.
16. Chang GC, Yang TY, Shih CM, Lin LY, Lee HS, Chiang CD. Serial-measured versus estimated creatinine clearance patients with non-small cell lung cancer receiving cisplatin-based chemotherapy. J Formos Med Assoc. 2003;102:257-261.